Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 21, 2007; 13(39): 5188-5195
Published online Oct 21, 2007. doi: 10.3748/wjg.v13.i39.5188
Published online Oct 21, 2007. doi: 10.3748/wjg.v13.i39.5188
Figure 3 A: Cumulative rate of first recurrence.
Rates of first recurrence for the IFN and non-IFN groups. The rate of first recurrence of HCC in the IFN group was not significantly different from that of the non-IFN group (P = 0.157); B: Cumulative rate of second recurrence. Rates of second recurrence for the IFN and non-IFN group. The rate of second recurrence of HCC in the IFN group was not significantly different from that of the non-IFN group (P = 0.056).
- Citation: Jeong S, Aikata H, Katamura Y, Azakami T, Kawaoka T, Saneto H, Uka K, Mori N, Takaki S, Kodama H, Waki K, Imamura M, Shirakawa H, Kawakami Y, Takahashi S, Chayama K. Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma. World J Gastroenterol 2007; 13(39): 5188-5195
- URL: https://www.wjgnet.com/1007-9327/full/v13/i39/5188.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i39.5188